271 related articles for article (PubMed ID: 21633975)
21. Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease.
Watanabe N; Araki W; Chui DH; Makifuchi T; Ihara Y; Tabira T
FASEB J; 2004 Jun; 18(9):1013-5. PubMed ID: 15084524
[TBL] [Abstract][Full Text] [Related]
22. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.
Yan R; Bienkowski MJ; Shuck ME; Miao H; Tory MC; Pauley AM; Brashier JR; Stratman NC; Mathews WR; Buhl AE; Carter DB; Tomasselli AG; Parodi LA; Heinrikson RL; Gurney ME
Nature; 1999 Dec; 402(6761):533-7. PubMed ID: 10591213
[TBL] [Abstract][Full Text] [Related]
23. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
[TBL] [Abstract][Full Text] [Related]
24. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
Carter CJ
Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
[TBL] [Abstract][Full Text] [Related]
25. Amyloid in skin and brain: what's the link?
Schreml S; Kaiser E; Landthaler M; Szeimies RM; Babilas P
Exp Dermatol; 2010 Nov; 19(11):953-7. PubMed ID: 20807234
[TBL] [Abstract][Full Text] [Related]
26. Alzheimer's disease-related lesions.
Alafuzoff I
J Alzheimers Dis; 2013; 33 Suppl 1():S173-9. PubMed ID: 22695621
[TBL] [Abstract][Full Text] [Related]
27. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease.
House E; Collingwood J; Khan A; Korchazkina O; Berthon G; Exley C
J Alzheimers Dis; 2004 Jun; 6(3):291-301. PubMed ID: 15201484
[TBL] [Abstract][Full Text] [Related]
28. [Formation and participation of nano-amyloids in pathogenesis of Alzheimer's disease and other amyloidogenic diseases].
Mal'tsev AV; Galzitskaia OV
Biomed Khim; 2010; 56(6):624-38. PubMed ID: 21395066
[TBL] [Abstract][Full Text] [Related]
29. The progression towards Alzheimer's disease described as a bistable switch arising from the positive loop between amyloids and Ca(2+).
De Caluwé J; Dupont G
J Theor Biol; 2013 Aug; 331():12-8. PubMed ID: 23614875
[TBL] [Abstract][Full Text] [Related]
30. Clinical observations with AN-1792 using TAPIR analyses.
Hock C; Nitsch RM
Neurodegener Dis; 2005; 2(5):273-6. PubMed ID: 16909009
[TBL] [Abstract][Full Text] [Related]
31. Ischemic rats as a model in the study of the neurobiological role of human beta-amyloid peptide. Time-dependent disappearing diffuse amyloid plaques in brain.
Pluta R; Barcikowska M; Misicka A; Lipkowski AW; Spisacka S; Januszewski S
Neuroreport; 1999 Nov; 10(17):3615-9. PubMed ID: 10619654
[TBL] [Abstract][Full Text] [Related]
32. Alzheimer's disease 2012: the great amyloid gamble.
Marchesi VT
Am J Pathol; 2012 May; 180(5):1762-7. PubMed ID: 22472273
[TBL] [Abstract][Full Text] [Related]
33. A "keto-enol" plaque buster mechanism to diminish Alzheimer's β-Amyloid burden.
Zoltán O; László P; Éva K; Béla V
Biochem Biophys Res Commun; 2020 Oct; 532(1):82-87. PubMed ID: 32828536
[TBL] [Abstract][Full Text] [Related]
34. Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies.
Hölscher C
Rev Neurosci; 2005; 16(3):181-212. PubMed ID: 16323560
[TBL] [Abstract][Full Text] [Related]
35. Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits.
Stefani M
Prog Neurobiol; 2012 Dec; 99(3):226-45. PubMed ID: 22450705
[TBL] [Abstract][Full Text] [Related]
36. Inhibiting the conversion of soluble amyloid-beta peptide into abnormally folded amyloidogenic intermediates: relevance for Alzheimer's disease therapy.
Soto C; Saborio GP; Permanne B
Acta Neurol Scand Suppl; 2000; 176():90-5. PubMed ID: 11261811
[TBL] [Abstract][Full Text] [Related]
37. Choline-containing phospholipids in microdissected human Alzheimer's disease brain senile plaque versus neuropil.
Gaudin M; Panchal M; Auzeil N; Duyckaerts C; Brunelle A; Laprévote O; Touboul D
Bioanalysis; 2012 Sep; 4(17):2153-5159. PubMed ID: 23013397
[TBL] [Abstract][Full Text] [Related]
38. Hormesis and amyloid-β protein: physiology or pathology?
Morley JE; Farr SA
J Alzheimers Dis; 2012; 29(3):487-92. PubMed ID: 22258515
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of amyloid formation: a strategy to delay the onset of Alzheimer's disease.
Lansbury PT
Curr Opin Chem Biol; 1997 Aug; 1(2):260-7. PubMed ID: 9667848
[TBL] [Abstract][Full Text] [Related]
40. The incubation period of Alzheimer's disease and the timing of tau versus amyloid misfolding and spreading within the brain.
Goudsmit J
Eur J Epidemiol; 2016 Feb; 31(2):99-105. PubMed ID: 27017509
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
